HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
General Virology

General Virology encompasses the study of viruses, microscopic infectious agents that can cause a wide range of diseases in humans, animals, plants, and even bacteria. Some viruses also have an outer envelope derived from the host cell membrane. Virologists study various aspects of viruses, including their structure, replication, transmission, pathogenesis, and evolution. Understanding these fundamental aspects of virology is crucial for the development of vaccines to prevent viral infections.

Vaccines work by stimulating the body's immune system to recognize and respond to specific viral antigens, such as viral proteins or surface molecules. By mimicking natural infection without causing illness, vaccines prime the immune system to produce antibodies and memory cells that provide long-lasting protection against future encounters with the virus. There are several types of vaccines, including live attenuated vaccines, inactivated vaccines, subunit vaccines, recombinant vaccines, and nucleic acid vaccines. Each type of vaccine utilizes different strategies to present viral antigens to the immune system and induce a protective immune response.

Live attenuated vaccines contain weakened forms of the virus that can still replicate but cause minimal or no disease. Inactivated vaccines contain viruses that have been killed or inactivated using heat, chemicals, or radiation. These vaccines are safe but may require booster doses to maintain immunity. Subunit vaccines contain purified viral antigens or protein subunits that stimulate an immune response. These vaccines are highly purified and do not contain live virus, making them safe for use in individuals with weakened immune systems. Recombinant vaccines are produced by genetically engineering viruses to express specific antigens. These vaccines are highly specific and can be tailored to target specific viral proteins or surface molecules. Examples include the recombinant hepatitis B vaccine and the recombinant subunit vaccine against COVID-19.

Submit your abstract Today

Watsapp